Serum calreticulin is a negative biomarker in patients with Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

http://www.wikidata.org/entity/Q34833657

about

Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy.Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity.Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer's disease.Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.Fighting the Cause of Alzheimer's and GNE Myopathy

P2860

Q39334546-7BF66F35-5642-453E-81B6-4763D72750EA Q42318626-5F443C69-1AF8-489F-8A2E-4E4E272BD2AF Q45874593-AC2F3ED7-7D2F-46FC-887F-8ED2039ECE4F Q48604859-C3295021-999D-4B45-B570-4A17FD09A712 Q58122164-E10AF747-7316-4240-8361-112A81A5CF96

P2860

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

http://www.wikidata.org/entity/Q34833657

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@ast

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@en

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@nl

type

label

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@ast

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@en

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@nl

prefLabel

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@ast

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@en

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@nl

P1433

Q34833657-106A6F32-6E0D-47B3-907B-46FCF278153A

P1476

Q34833657-CBFCE1C6-732C-443B-A671-5DE50F87BFFC

P2093

Q34833657-1388C042-9828-41A1-B300-74C42F3C1D5E

Q34833657-AE9CA75C-F384-44D4-9FC6-663443305D1C

Q34833657-B9B28A74-2633-4C1A-8E37-D3839FD9F71D

P2860

Q34833657-057DE799-FD91-4019-89F3-36EA8962EF33

Q34833657-08CB7472-3F99-40FE-B120-790DDC151958

Q34833657-0CDCC782-91E9-4499-B6B3-86538D4D998F

Q34833657-118B5828-918E-4527-9A27-CCDF64C5A78A

Q34833657-11942390-BE1F-4AB9-B9C7-F7A0BC44C223

Q34833657-1435A605-9B7F-43C3-B2D8-F559FABC4075

Q34833657-1500C3B0-9133-4174-A81F-F94BBCBE80A6

Q34833657-1940CD3B-EF36-444D-AFFC-A928469C30D3

Q34833657-1A50BEAA-9088-4525-B142-FD572FB5AAA6

Q34833657-1AF07584-8751-4453-9746-702DD71C804A

P304

Q34833657-BA0348D2-4AB0-48D8-8D64-128FD427F7D0

P31

Q34833657-62126BA0-1A59-4619-B49A-06C69C0490B2

P356

Q34833657-67539158-3506-49EF-B48D-D19B72421211

P407

Q34833657-36743A10-1C9E-4FD2-B0DC-4A064F5E709B

P433

Q34833657-7B8301AF-9BF4-4AEA-86DB-9480DD88BFC5

P478

Q34833657-CBC6221D-514C-422C-BAFB-3E93FB872ECF

P577

Q34833657-925DA7D9-306E-4C05-95FD-1ED28F3E0125

P5875

Q34833657-07B7317F-4495-4058-97CA-D7AF85A47AC4

P698

Q34833657-CE60536E-179A-4C76-8F70-629FE8C657B2

P921

Q34833657-7CC970C1-9C24-42CE-87B3-48A410130370

P932

Q34833657-D929A51F-4B63-4028-97DB-4B5707873C04

P356

P1433

International Journal of Molecular Sciences

P1476

Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

@en

P2093

Jie Gao

http://www.w3.org/2001/XMLSchema#string

Qiao Lin

http://www.w3.org/2001/XMLSchema#string

Yunpeng Cao

http://www.w3.org/2001/XMLSchema#string

P2860

A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk

Calorie restriction and aging in nonhuman primates

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

Epidemiology of Alzheimer disease

Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain

Chaperonins are cell-signalling proteins: the unfolding biology of molecular chaperones

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

Elevated serum pesticide levels and risk for Alzheimer disease

Amyloid-β peptide-specific DARPins as a novel class of potential therapeutics for Alzheimer disease

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

P304

21740-21753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS151221740

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268880961

http://www.w3.org/2001/XMLSchema#string

P698

25429433

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4284675

http://www.w3.org/2001/XMLSchema#string